Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
Coco M Fuhri SnethlageAbraham S MeijnikmanAnne Linde MakElena RampanelliBas VoermansCengiz A K CallenderPleun de GroenBart O RoepDaniël H van RaalteFilip K Krag KnopAdriaan G HolleboomMax NieuwdorpNordin M J HanssenPublished in: European journal of endocrinology (2024)
Individuals with type 1 diabetes and high blood pressure, older age, higher BMI, and longer duration of disease could be considered at high-risk for developing MASLD.